Physician profile
Scott E Anderson
NPI 1497897748
$3,117.02
in general payments reported to CMS, 2019-2025
24 companies · $309 in 2025
The $309 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $372 · 2022: $680 · 2023: $669 · 2024: $1,087 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,065.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,177.09 | 2022-2024 | Proclaim, Prodigy |
| Collegium Pharmaceutical, INC. | $315.92 | 2021-2025 | Belbuca, Nucynta, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $275.72 | 2022-2025 | Relistor |
| Nevro Corp. | $244.32 | 2021 | |
| Abbvie INC. | $189.86 | 2024-2025 | |
| Azurity Pharmaceuticals, INC. | $163.54 | 2023-2025 | Horizant, Horizant |
| Ibsa Pharma INC. | $148.59 | 2021-2024 | Tirosint, Licart, Tirosint |
| Medtronic, INC. | $70.84 | 2024 | Intellis Adaptivestim, Synchromedii |
| Boston Scientific Corporation | $53.06 | 2024-2025 | Wavewriter Alpha Prime 16, Intracept |
| Horizon Therapeutics Plc | $52.00 | 2021 | |
| Pfizer INC. | $51.82 | 2023-2024 | |
| Axsome Therapeutics, INC. | $50.52 | 2025 | Symbravo |
| Tersera Therapeutics LLC | $48.37 | 2025 | Prialt |
| Arbor Pharmaceuticals, INC. | $41.90 | 2022 | |
| Globus Medical, INC. | $34.87 | 2025 | Senza |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $32.53 | 2023-2024 | On-Q* Pump and Accessories, Generator |
| Averitas Pharma INC. | $31.67 | 2024 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $23.90 | 2025 | |
| Amgen INC. | $22.32 | 2021 | |
| Impel Pharmaceuticals LLC | $22.08 | 2025 | Trudhesa |
| Pacira Therapeutics, INC. | $18.67 | 2021 | |
| Tonix Medicines, INC. | $18.64 | 2025 | Tonmya |
| Convatec INC. | $14.51 | 2024 | |
| Bioventus LLC | $14.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.